MicroRNA-9 Suppresses the Growth, Migration, and Invasion of Malignant Melanoma Cells via Targeting NRP1

OncoTargets and Therapy - New Zealand
doi 10.2147/ott.s107235
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Informa UK Limited

Related search

miR‑124 Inhibits Proliferation, Migration and Invasion of Malignant Melanoma Cells via Targeting Versican

Experimental and Therapeutic Medicine
MedicineCancer ResearchImmunologyMicrobiology
2017English

MicroRNA-129-5p Suppresses Cell Proliferation, Migration and Invasion via Targeting ROCK1 in Osteosarcoma

Molecular Medicine Reports
OncologyGeneticsMolecular BiologyBiochemistryCancer ResearchMolecular Medicine
2018English

MicroRNA‑3666 Suppresses the Growth and Migration of Glioblastoma Cells by Targeting KDM2A

Molecular Medicine Reports
OncologyGeneticsMolecular BiologyBiochemistryCancer ResearchMolecular Medicine
2018English

MicroRNA-326 Suppresses the Proliferation, Migration and Invasion of Cervical Cancer Cells by Targeting ELK1

Oncology Letters
Cancer ResearchOncology
2017English

MicroRNA-663 Inhibits the Proliferation, Migration and Invasion of Glioblastoma Cells via Targeting TGF-β1

Oncology Reports
MedicineCancer ResearchOncology
2015English

MicroRNA-664 Suppresses the Growth of Cervical Cancer Cells via Targeting C-Kit

Drug Design, Development and Therapy
Drug DiscoveryPharmacologyPharmaceutical Science
2019English

MicroRNA-485-5p Suppresses the Proliferation, Migration and Invasion of Small Cell Lung Cancer Cells by Targeting Flotillin-2

Bioengineered
Applied MicrobiologyBiotechnologyMedicineBioengineering
2019English

miR-127 Suppresses Gastric Cancer Cell Migration and Invasion via Targeting Wnt7a

Oncology Letters
Cancer ResearchOncology
2019English

MicroRNA-182 Suppresses Clear Cell Renal Cell Carcinoma Migration and Invasion by Targeting IGF1R

Neoplasma
Cancer Research
2016English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy